Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 11 (8)

Immunometabolism in Cancer at a Glance

Affiliations
Review

Immunometabolism in Cancer at a Glance

Katrin Singer et al. Dis Model Mech.

Abstract

The scientific knowledge about tumor metabolism has grown at a fascinating rate in recent decades. We now know that tumors are highly active both in their metabolism of available nutrients and in the secretion of metabolic by-products. However, cancer cells can modulate metabolic pathways and thus adapt to specific nutrients. Unlike tumor cells, immune cells are not subject to a 'micro-evolution' that would allow them to adapt to progressing tumors that continuously develop new mechanisms of immune escape. Consequently, immune cells are often irreversibly affected and may allow or even support cancer progression. The mechanisms of how tumors change immune cell function are not sufficiently explored. It is, however, clear that commonly shared features of tumor metabolism, such as local nutrient depletion or production of metabolic 'waste' can broadly affect immune cells and contribute to immune evasion. Moreover, immune cells utilize different metabolic programs based on their subtype and function, and these immunometabolic pathways can be modified in the tumor microenvironment. In this review and accompanying poster, we identify and describe the common mechanisms by which tumors metabolically affect the tumor-infiltrating cells of native and adaptive immunity, and discuss how these mechanisms may lead to novel therapeutic opportunities.

Keywords: Cancer; Metabolism; Metabolites; Nutrients; T cells; Tumor immunology.

Conflict of interest statement

Competing interestsThe authors declare that they do not have any competing or financial interests.

Similar articles

See all similar articles

Cited by 10 articles

See all "Cited by" articles

References

    1. Al-Khami A. A., Zheng L., Del Valle L., Hossain F., Wyczechowska D., Zabaleta J., Sanchez M. D., Dean M. J., Rodriguez P. C. and Ochoa A. C. (2017). Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. Oncoimmunology 6, e1344804 10.1080/2162402X.2017.1344804 - DOI - PMC - PubMed
    1. Amara S. and Tiriveedhi V. (2017). Inflammatory role of high salt level in tumor microenvironment (Review). Int. J. Oncol. 50, 1477-1481. 10.3892/ijo.2017.3936 - DOI - PubMed
    1. Amara S., Zheng M. and Tiriveedhi V. (2016). Oleanolic acid inhibits high salt-induced exaggeration of Warburg-like metabolism in breast cancer cells. Cell Biochem. Biophys. 74, 427-434. 10.1007/s12013-016-0736-7 - DOI - PMC - PubMed
    1. Amara S., Majors C., Roy B., Hill S., Rose K. L., Myles E. L. and Tiriveedhi V. (2017). Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation. PLoS ONE 12, e0180097 10.1371/journal.pone.0180097 - DOI - PMC - PubMed
    1. Ando T., Mimura K., Johansson C. C., Hanson M. G., Mougiakakos D., Larsson C., Martins Da Palma T., Sakurai D., Norell H., Li M. et al. (2008). Transduction with the antioxidant enzyme catalase protects human T cells against oxidative stress. J. Immunol. 181, 8382-8390. 10.4049/jimmunol.181.12.8382 - DOI - PubMed

Publication types

LinkOut - more resources

Feedback